The landscape of breast cancer treatment is undergoing a fundamental paradigm shift. For decades, the prevailing philosophy...
Patient Advocacy and Support
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) medications have emerged as...
NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...
For decades, the standard of care for aggressive breast cancer followed a "more is better" philosophy. In...
For decades, the standard of care for aggressive breast cancer was defined by a "more is better"...
Introduction: A Growing Conversation In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor agonists have surged into the medical...
NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...
MADRID, SPAIN – As the global oncology community prepares to descend upon the Spanish capital for the...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) The landscape of medical treatment is...
NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a...
